NCT00512278View on ClinicalTrials.gov

Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C

PHASE2CompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Hepatitis C
Interventions
DRUG

Infliximab

Infliximab weight based injection at baseline, weeks 2,6,14,22,30,38,46

DRUG

Placebo

Placebo

Trial Locations (7)

32127

Advanced Medical Research Center, Port Orange

44106

Case Medical Center, Cleveland

44195

Cleveland Clinic, Cleveland

75203

The Liver Institute at Methodist Dallas, Dallas

78234

Brooke Army Medical Center, San Antonio

90048

Cedars-Sinai Medical Center, Center for Liver Disease and Transplantation, Los Angeles

440292

University of Louisville, Louisville

Sponsors

Collaborators (1)

Centocor, Inc.
All Listed Sponsors
collaborator

Centocor, Inc.

INDUSTRY

lead

Nizar Zein

OTHER